Study Shows Tarcocimab May Improve Diabetic Retinopathy

A phase 3 trial showed that tarcocimab, a biopolymer with a vascular growth factor antibody, improved vision and anatomical markers in patients with early stage diabetic retinopathy.
Medscape Medical News

Full Story →